Oncology

September 2014 Focus

In this Issue: Focus on Pain Telecare Program Effectively Manages Pain, Reduces Opioid Use in VA Patients Research Finds Unexpectedly High Rates of Pain, Opioid Use in Recently Deployed Soldiers Pharmacy Update Statins Reduce Barrett‘s Esophagus; Cancer Precursor Affects About… Read More

Computer Model: HCV, Associated Cancer Will Be Rare by 2036

Computer Model: HCV, Associated Cancer Will Be Rare by 2036

By Brenda L. Mooney PITTSBURGH – Will hepatitis C become a rare disease over the next two decades or so? The answer is yes, according to a computer simulation conducted by the University of Pittsburgh Graduate School of Public Health… Read More

VA, DoD Remain on Front Lines in Ongoing War Against Cancer

VA, DoD Remain on Front Lines in Ongoing War Against Cancer

FORT LEWIS-MCCHORD, WA – The DoD’s leadership in cancer research started accidentally, but funding from Congress has ensured that both the Army and VA have remained on the front lines in the war on cancer during the past 50 years.

VA Proposes Physician Pay Increases, Begins Major Recruiting Campaign

VA Proposes Physician Pay Increases, Begins Major Recruiting Campaign

By Sandra Basu WASHINGTON – The maximum rates of annual pay for incoming VHA physicians and dentists would be increased as much as $35,000, under a VA proposal announced last month. The updated pay tables would allow physicians and dentists… Read More

Male Breast Cancer at the VA Much Rarer Than the Female Disease, but More Deadly

Male Breast Cancer at the VA Much Rarer Than the Female Disease, but More Deadly

Annette M. Boyle WASHINGTON – Men are diagnosed with less than 0.1% of all breast cancers, but for those unfortunate few, the disease extracts a high toll — and a 65% increase in mortality risk compared to women. The interpretation… Read More

Increasing Cancer Treatment Delays Have Plagued VAMCs for Nearly a Decade

Increasing Cancer Treatment Delays Have Plagued VAMCs for Nearly a Decade

Some Long Wait Times Attributable to Treatment Modalities by Annette M. Boyle CHICAGO – The news media frenzy of the last six months might suggest otherwise, but concerns about delays in treatment for veterans are nothing new at the VA,… Read More

Montana Nurse Manager Introduced ‘Navigator’ to Guide Patients Through VA Care

Montana Nurse Manager Introduced ‘Navigator’ to Guide Patients Through VA Care

By Steve Lewis FORT HARRISON, MT – As a cancer survivor herself and with two sisters who are cancer patients, Debera Charlton, RN, was acutely aware of the benefits of having a nurse navigator.“The nurse navigator is used widely in the… Read More

June 2014 Focus

In this Issue: Focus on PTSD/TBI Brain Injury from Blasts Possible Without TBI Symptoms VA/Court Partnerships Seek to Keep Troubled Veterans Out of Jail Pharmacy Update TRICARE Limits on Use of Community Pharmacies Creates Firestorm Pain Clinical Consult Chronic Pain… Read More

May 2014 Focus

In this Issue: Focus on Women’s Health New Mothers May Need Training to Pass Postpartum Military Fitness Test Gene Sequencing Helps Target Therapies for Metastatic Breast Cancer Pharmacy Update Consolidated Pharmacy Services in Military to Save $2B by 2019 Osteoarthritis… Read More

April 2014 Focus

In this Issue: News Update Intensive BP-Lowering Didn’t Affect Cognitive Function in Diabetes Focus on Men’s Health New Study: Are ‘Low T’ Guidelines Followed in VA? Prostate Cancer Recurrence Risk Rises 50% with Elevated Glucose Levels Pharmacy Update VA’s Mail-Order… Read More

New Cervical Cancer Indication Approved for Avastin

SOUTH SAN FRANCISCO, CA – A new use has been approved for bevacizumab, marketed as Avastin, to treat patients with persistent, recurrent or metastatic cervical cancer. The new indication for Avastin, which interferes with the blood vessels that fuel the… Read More

Psychological Distress Affects Prostate Cancer Screening

BOSTON – As the debate continues about the benefit of routine prostate cancer screening, a new VA study raises a new concern: the role of psychological distress in the process. The study, led by researchers from the VA Boston Healthcare… Read More

Statins Reduce Recurrence after Prostate Cancer Surgery

DURHAM, NC – Patients should be prescribed statins after prostate cancer surgery, according to the authors of a new retrospective analysis which finds that men whobegin taking the cholesterol-lowering drugs after radical prostatectomy are less likely to have a recurrence… Read More

Prostate Cancer More Aggressive in Younger Men

ANN ARBOR, MI – Prostate cancer diagnoses are on the increase in younger men, and a new analysis suggested that the disease is typically more aggressive in those cases. The study, conducted by researchers from the Ann Arbor, MI, VAMC,… Read More

Statins Reduce Barrett’s Esophagus; Cancer Precursor Affects About 10% of Veterans

Statins Reduce Barrett’s Esophagus; Cancer Precursor Affects About 10% of Veterans

By Annette M. Boyle BETHESDA, MD – Veterans on statins have another good reason to continue to take their medication, according to new research. Statins not only reduce cholesterol, combat cardiovascular disease and potentially reduce the risk of prostate cancer,… Read More

Military Nurse-Researcher Learned New Field to Help PTSD Patients

By Steve Lewis Spending much of her career as an oncology nurse, Stacey Young-McCaughan, RN, PhD, a retired Army colonel and professor at the University of Texas Health Science Center at San Antonio School of Medicine, was a little unsure… Read More

Advisory Group: Exposures, Not Stress Caused Gulf War Illness

Advisory Group: Exposures, Not Stress Caused Gulf War Illness

By Sandra Basu WASHINGTON – Exposures to pesticides and pyridostigmine bromide are causally associated with Gulf War illness, according to a new report which also said evidence continues to demonstrate that Gulf War illness is not the result of psychological… Read More

Cyramza Receives Fast-Track Approval for Advanced Stomach Cancer

INDIANAPOLIS – A new therapy has received fast-track approval for treatment of advanced stomach cancer. The Food and Drug Administration has approved Cyramza (ramucirumab) to treat patients with gastroesophageal junction adenocarcinoma. Cyramza, marketed by Eli Lilly of Indianapolis, is an… Read More

Repeat Colonoscopy Recommendations Usually Meet Guidelines

ANN ARBOR, MI – Physician endoscopists’ recommendations for timing of surveillance colonoscopy in average-risk patients with one to two small polyps are consistent with guideline recommendations in about 90% of cases, according to a new study. The study, which was… Read More

Military Nurse-Researcher Learned New Field to Help PTSD Patients

Military Nurse-Researcher Learned New Field to Help PTSD Patients

By Steve Lewis LLANO, TX – Spending much of her career as an oncology nurse, Stacey Young-McCaughan, RN, PhD, a retired Army colonel and professor at the University of Texas Health Science Center at San Antonio School of Medicine, was… Read More